Immunogenicity of Co-administered Oral Polio Vaccine and Oral Cholera Vaccine
Study on the Immunogenicity of Oral Polio Vaccine (OPV) and Oral Cholera Vaccine (OCV) When Co-administered
Sponsor: Centers for Disease Control and Prevention
A PHASE3 clinical study on Vaccine Reaction, this trial is ongoing. The trial is conducted by Centers for Disease Control and Prevention and has accumulated 9 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Apr 2024 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Apr 2022 — Apr 2024 [monthly]
Recruiting PHASE3
-
Mar 2021 — Apr 2022 [monthly]
Recruiting PHASE3
▶ Show 4 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE3
-
Jun 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Sep 2019 — Jun 2020 [monthly]
Recruiting PHASE3
-
Aug 2018 — Sep 2019 [monthly]
Recruiting PHASE3
First recorded
Jul 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centers for Disease Control and Prevention
- International Centre for Diarrhoeal Disease Research, Bangladesh
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .